title: Are prolonged/continuous infusions of β-lactams for all?
authors.forename: Rajeev
authors.initials: R
authors.lastname: Soman
authors.forename: Neha
authors.initials: N
authors.lastname: Gupta
authors.forename: Anjali
authors.initials: A
authors.lastname: Shetty
authors.forename: Camilla
authors.initials: C
authors.lastname: Rodrigues
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D015780:Carbapenems / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D010397:Penicillanic Acid / Q000031:analogs & derivatives*; D010878:Piperacillin / Q000008:administration & dosage*; D018805:Sepsis / Q000188:drug therapy*; D047090:beta-Lactams / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems; D047090:beta-Lactams; D010397:Penicillanic Acid; D010878:Piperacillin